Viatris

Ultime notizie

Titoli nella lingua originale della fonte.

• Viatris (VTRS) Q2 2026 Earnings Call Transcript (si apre in una nuova scheda)

  Fortune · 1 ott 2026

• Viatris Inc. stock falls Wednesday, underperforms market (si apre in una nuova scheda)

  MarketWatch · 30 set 2026

• Viatris Inc. (VTRS) Stock Price, News, Quote & History (si apre in una nuova scheda)

  Yahoo! Finance Canada · 30 set 2026

• Viatris Facing Multiple Paths to Earnings Growth, Oppenheimer Says (si apre in una nuova scheda)

  Moomoo · 30 set 2026

• Net income before discontinued operations of Viatris, Inc. – HAN:VIA (si apre in una nuova scheda)

  TradingView · 30 set 2026

• Viatris named to Forbes' World's Best Employers list for sixth year, highlighting strong workplace culture. (si apre in una nuova scheda)

  Pluang · 29 set 2026

• Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year (si apre in una nuova scheda)

  PR Newswire · 29 set 2026

• Viatris stock hits 52-week high at 18.4 USD (si apre in una nuova scheda)

  Investing.com · 29 set 2026

• Will Japan WAKIX Approval Change Viatris (VTRS) Stock Narrative (si apre in una nuova scheda)

  Simply Wall Street · 28 set 2026

• Viatris Inc. stock rises Monday, outperforms market (si apre in una nuova scheda)

  MarketWatch · 28 set 2026

• Is Viatris (VTRS) Cheap On Its Japan WAKIX Approval? (si apre in una nuova scheda)

  Simply Wall Street · 27 set 2026

• Viatris (VTRS) Q1 2026 Earnings Call Transcript (si apre in una nuova scheda)

  Fortune · 26 set 2026

• Viatris Inc. (VTRS) stock price, news, quote and history (si apre in una nuova scheda)

  Yahoo Finance Singapore · 26 set 2026

• Viatris Inc. stock rises Friday, outperforms market (si apre in una nuova scheda)

  MarketWatch · 25 set 2026

• Viatris sues Novo Nordisk, seeks to market generic Wegovy (si apre in una nuova scheda)

  Seeking Alpha · 25 set 2026

• Viatris sues Novo Nordisk over generic Wegovy patent dispute (si apre in una nuova scheda)

  Yahoo Finance · 25 set 2026

• Viatris Appoints Joe Paul Philip to Lead Manufacturing Science and Technology in Three Markets (si apre in una nuova scheda)

  konsulteer.com · 25 set 2026

• Is Viatris Stock Outperforming the S&P 500? (si apre in una nuova scheda)

  Yahoo Finance · 24 set 2026

• How Viatris Inc. (VTRS) Affects Rotational Strategy Timing (si apre in una nuova scheda)

  Stock Traders Daily · 24 set 2026

• Viatris (VTRS) Short Interest & Short Float | Updated Sep 2026 $VTRS (si apre in una nuova scheda)

  marketbeat.com · 24 set 2026

• Oppenheimer Says Viatris Looks Mispriced As Just A Generics Play (si apre in una nuova scheda)

  Finimize · 23 set 2026

• Viatris Price Target Announced at $25.00/Share by Oppenheimer (si apre in una nuova scheda)

  Moomoo · 23 set 2026

• Oppenheimer initiates Viatris stock with outperform rating (si apre in una nuova scheda)

  Investing.com · 23 set 2026

• Oppenheimer Initiates Viatris at Outperform With $25 Price Target (si apre in una nuova scheda)

  Yahoo Finance · 23 set 2026

• Viatris (VTRS) Institutional Ownership 2026 $VTRS (si apre in una nuova scheda)

  marketbeat.com · 23 set 2026

• Viatris (VTRS) Wins Japan WAKIX Approval. Can it Build a Meaningful Specialty Business? (si apre in una nuova scheda)

  Yahoo Finance · 20 set 2026

• Viatris (VTRS) Gains Japan WAKIX Approval As Fair Value Still Sits Higher (si apre in una nuova scheda)

  Simply Wall Street · 19 set 2026

• Viatris Stock Price Forecast. Should You Buy VTRS? (si apre in una nuova scheda)

  StockInvest.us · 18 set 2026

• Viatris’ Wakix receives Japanese approval to treat OSAS and narcolepsy (si apre in una nuova scheda)

  Yahoo · 17 set 2026

• Could Japan Sleep Drug Approval Alter The Investment Case For Viatris (VTRS)? (si apre in una nuova scheda)

  Simply Wall Street · 16 set 2026